Ana Filipa Cruz e Costa

Team icon

Publications

Show less

Information about journal articles, updated at 13-10-2024, from platform CIÊNCIAVITAE.

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency

Conde, Bebiana; Costa, Filipa; Gomes, Joana; Lopes, António Paulo; Mineiro, Maria Alexandra; Rodrigues, Orlando; Santos, Cristina; et al, Acta Médica Portuguesa. 13. 35. 2022. http://dx.doi.org/10.20344/amp.18497 . 10.20344/amp.18497 . Acta Médica Portuguesa

Alpha-1-antitrypsin deficiency (AATD) and spontaneous pneumothorax: Guidelines do not recommend screening for AATD in patients with pneumothorax – What did we find in 10 years of clinical evidence?

Dias, E.; Farinha, I.; Costa, F., Pulmonology. 80 - 81. 1. 27. 2021. http://dx.doi.org/10.1016/j.pulmoe.2020.05.014 . 10.1016/j.pulmoe.2020.05.014 . published Pulmonology

Pulmonary rehabilitation: a unfairly forgotten therapeutic tool even in the worst scenarios

Joana Paixão; Joana Cascais Costa; Cidália Rodrigues; Filipa Costa; Leonor Aleluia, Revista da Associação Médica Brasileira. 2021. https://doi.org/10.1590/1806-9282.20210377 . 10.1590/1806-9282.20210377 . published Revista da Associação Médica Brasileira

Alpha1- Antitrypsin Deficiency: Principles of Care.

JF Rodrigues, Acta Med Port.. 433 - 439. 6. 33. 2020. https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12950 . published Acta Med Port.

Portuguese consensus document for the management of alpha-1-antitrypsin deficiency

A P Lopes 1, Pulmonology. 1 - 21. Suppl 1. 24. 2018. https://www.sciencedirect.com/science/article/pii/S2531043718301351?via%3Dihub . published Pulmonology

Can we change a genetically determined future?

L Fernandes, BMJ Case Rep. 2015. 2015. Doi:10.1136/bcr-2013-200797 . published BMJ Case Rep

Spontaneous splenic rupture in a patient with small-cell lung cancer.

L Fernandes, BMJ Case Rep . 2013. 2013. Doi:10.1136/bcr-2013-010325 . published BMJ Case Rep

Severe a-1 antitrypsin deficiency caused by Q0Ourem ´allele: clinical features, haplotype characterization and history.

LV Rodrigues, characterization and history. Clin Genet 2012; 81(5):462–469. . 462 - 469. 5. 81. 2012. Doi: 10.1111/j.1399-0004.2011.01670.x. . published characterization and history. Clin Genet 2012; 81(5):462–469.

Pneumonia associada aos cuidados de saúde versus pneumonia adquirida na comunidade: entidades diferentes, abordagens distintas

Guimarães, C.; Lares Santos, C.; Costa, F.; Barata, F., Revista Portuguesa de Pneumologia. 168 - 171. 4. 17. 2011. http://dx.doi.org/10.1016/j.rppneu.2011.01.001 . 10.1016/j.rppneu.2011.01.001 . Revista Portuguesa de Pneumologia

Sarcoidose extratorácica

Costa, Filipa; Arrobas, Ana, Revista Portuguesa de Pneumologia. 127 - 140. 1. 14. 2008. http://dx.doi.org/10.1016/s0873-2159(15)30222-1 . 10.1016/s0873-2159(15)30222-1 . Revista Portuguesa de Pneumologia

Endometriose torácica

Costa, Filipa; Matos, Fernando, Revista Portuguesa de Pneumologia. 427 - 435. 3. 14. 2008. http://dx.doi.org/10.1016/s0873-2159(15)30250-6 . 10.1016/s0873-2159(15)30250-6 . published Revista Portuguesa de Pneumologia

Treatment of non-small cell lung cancer in elderly patients

F Costa, F Barata. , Rev Port Pneumol. 841 - 854. 6. XIII. 2007. published Rev Port Pneumol

Exhaled nitric oxide in asthma diagnosis

F Costa, A Arrobas. , Rev Port Imunoalergologia . 163 - 167. 2. 15. 2007. published Rev Port Imunoalergologia

Small cell lung cancer – State of the art and future perspectives.

F Barata, F Costa. , Rev Port Pneumol . 587 - 604. 4. XII. 2007. published Rev Port Pneumol

All projects

Show less

Information of exclusive responsibility of the researcher 13-10-2024 , from platform CIÊNCIAVITAE.

2013 - 2014

A phase 3 trial to evaluate the efficacy and safety of tiotropium, delivered by the Respimat Soft Mist Inhaler (SMI) in adolescents patients with severe asthma

PensieTinA-asthma (BI 205.456)

Researcher

Centro Hospitalar e Universitário de Coimbra EPE

2008 - 2008

A comparison of Symbicort® Single Inhaler Therapy (Symbicort® 160/4,5 mcg, 1 inhalation b.i.d. plus as needed) and conventional best practise for the treatment of persistent asthma in adolescents and adults – a 26 week, randomised, open-label, parallel group, multicentre study.

STYLE

Researcher

2006 - 2008

A randomized, double blind, placebo controlled dose and schedule finding trial to evaluate the safety and efficacy of AMG531 for the treatment of chemotherapy-induced trombocytopenia in subjects with advanced non-small cell lung cancer already receiving gemcitabine and platinum

AMG531

Researcher

2004 - 2007

A randomized phase 3 trial of ALIMTA® and cisplatin versus GEMZAR® and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.

GALES

Researcher

2003 - 2005

A 24-week, double-blind, parallel group, placebo and active controlled study to investigate the efficacy and safety of daily roflumilast taken with low dose inhaled corticosteroids in patients with chronic asthma.

PEGASUS

Researcher

We use cookies to improve your visit to our website.